LifeStance Health Group, Inc. (LFST) revealed Loss for full year of -$57.443 million
The company's earnings totaled -$57.443 million, or -$0.15 per share. This compares with -$186.262 million, or -$0.51 per share, last year.
The company's revenue for the period rose 18.6% to $1.251 billion from $1.055 billion last year.
LifeStance Health Group, Inc. earnings at a glance (GAAP) :
-Earnings: -$57.443 Mln. vs. -$186.262 Mln. last year.
-EPS: -$0.15 vs. -$0.51 last year.
-Revenue: $1.251 Bln vs. $1.055 Bln last year.
Looking ahead, LifeStance Health Group expects a rise in first quarter and annual revenue.
For the first-quarter of 2025, the company expects adjusted EBITDA of $27 to $33 million, with revenue of $320 to $340 million.
For the first-quarter of 2024, the Group had recorded adjusted EBITDA of $27.7 million, on revenue of $300.4 million.
For the full-year 2025, the Group projects adjusted EBITDA of $130 to $150 million, with revenue of $1.40 to $1.44 billion.
For the full-year 2024, the company had recorded adjusted EBITDA of $119.7 million, on revenue of $1.251 billion.
For comments and feedback: editorial@rttnews.com